Vascular Endothelial Growth Factor-B Blockade with CSL346 in Diabetic Kidney Disease: A Phase 2A Randomized Controlled Trial.

ABSTRACT:

SUBMITTER: Cooper M 

PROVIDER: S-EPMC11543004 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature